Literature DB >> 7793065

Inhibition of pseudorabies virus replication by a chimeric trans-gene product repressing transcription of the immediate-early gene.

E Ono1, Y Sakoda, S Taharaguchi, S Watanabe, N Tonomura, H Kida, Y Shimizu.   

Abstract

A chimeric gene encoding a fusion protein consisting of the DNA-binding domain of the immediate-early (IE) protein of pseudorabies virus (PRV) and a tail-truncated Vmw65 of herpes simplex virus 1, lacking the transcription activation domain, was constructed. The chimeric gene product inhibited transcription from the PRV IE promoter in a transient expression assay. A HeLa cell line stably transformed with the chimeric gene showed remarkable resistance to PRV infection. In the transformed cells infected with PRV, transcription of the PRV IE gene was repressed, indicating that the resistance of the cells to PRV infection was due to interference with IE gene transcription by the fusion protein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7793065     DOI: 10.1006/viro.1995.1324

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  3 in total

1.  Transgenic mice expressing a soluble form of porcine nectin-1/herpesvirus entry mediator C as a model for pseudorabies-resistant livestock.

Authors:  Etsuro Ono; Keiko Amagai; Satoshi Taharaguchi; Yukiko Tomioka; Saori Yoshino; Yuki Watanabe; Pierre Cherel; Louis-Marie Houdebine; Micheline Adam; Marc Eloit; Manabu Inobe; Toshimitsu Uede
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-08       Impact factor: 11.205

2.  Dominant-negative proteins in herpesviruses - from assigning gene function to intracellular immunization.

Authors:  Hermine Mühlbach; Christian A Mohr; Zsolt Ruzsics; Ulrich H Koszinowski
Journal:  Viruses       Date:  2009-10-19       Impact factor: 5.048

3.  Cytomegalovirus replicon-based regulation of gene expression in vitro and in vivo.

Authors:  Hermine Mohr; Christian A Mohr; Marlon R Schneider; Laura Scrivano; Barbara Adler; Simone Kraner-Schreiber; Angelika Schnieke; Maik Dahlhoff; Eckhard Wolf; Ulrich H Koszinowski; Zsolt Ruzsics
Journal:  PLoS Pathog       Date:  2012-06-07       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.